Hims & Hers fell on fear that Novo Nordisk would take action against the company's new oral GLP-1, but there's more to the ...

Telehealth company Hims & Hers is launching a cheaper, off-brand version of the blockbuster weight loss pill Wegovy ...

Novo’s shares plunged after telehealth firm Hims & Hers Health Inc. launched a cheaper copycat version of its Wegovy pill.

By Maggie Fick LONDON, Feb 5 (Reuters) - Novo Nordisk CEO Mike Doustdar was in a meeting with investors on Thursday ...

By Amina Niasse NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health on Thursday began offering a much ...

Hims & Hers Health launched a cheaper, compounded version of the new Wegovy pill in a move that reignites its competition ...

Hims & Hers said it would begin offering copies of Wegovy for an introductory price of $49 for the first month with a ...

COPENHAGEN, Feb 5 (Reuters) - ‌Novo ​Nordisk said ‌on Thursday it would ​take legal action against Hims & ‍Hers after the ...

Hims & Hers (HIMS) stock jumps as the company plans to launch cheaper compounded versions of Novo Nodisk's (NVO) Wegovy pill.